6 Small-Cap REIT Stocks with Extremely High Dividend Yields and Positive Performance for 2013

Michael Teague  |

While conventional wisdom has it that it is more often the larger companies that can afford the luxury of rewarding and luring in investors with healthy dividends, REITs are designed with high dividend payouts in mind, and thus even the small-caps in this sector offer impressive yields.

A Real Estate Investment Trust, or REIT, is a security that is sold in the same way as a stock. REITs invest in real estate directly via properties and mortgages and benefit from special tax exemptions. Some REITs focus on a certain type of real estate (commercial, residential, industrial) or a specific region, state, or country. REITs are known for their typically very high dividend yields.

There are currently six REITs offering yields over 10 percent, whose shares have gained over 10 percent year-to-date for 2013.

New York Mortgage Trust Inc. (NYMT) – With a market cap of $359.47 million, and shares trading at $7.24, New York Mortgage Trust invests in assets such as residential mortgage backed securities (RMBS), prime adjustable rate mortgage loans (ARM), and commercial mortgage backed securities (CMBS).  NYMT currently has an annual dividend yield of 14.92 percent, with shares up 18.69 percent in 2013.

American Capital Mortgage Investment (MTGE) – Up 14.24 percent so far this year, American Capital Mortgage Investment is a diversified REIT managing a leveraged portfolio of mortgage-related investments. With a market cap of $250.18 million, and shares at $26, MTGE’s annual dividend yield is currently 13.85 percent.

AG Mortgage Investment Trust (MITT) – AG Mortgage Investment Trust is a diversified REIT that invests in real estate, residential securities and mortgage assets, as well as financial assets.  Its market cap is $677.96 million, with shares currently at $24.68 and an annual dividend yield of 12.97 percent.  AG Mortgage is up 8.39 percent in 2013.

Apollo Residential Mortgage (AMTG) – The residential REIT has a market cap of $672.61 million, with shares at $21.69 and a 10.89 percent gain for the year.  Apollo manages residential mortgage assets throughout the U.S. and has an annual dividend yield of 12.91 percent.

Resource Capital Corp. (RSO) – Resource Capital specializes in commercial real-estate assets and some commercial finance assets.  RSO has a market cap of $693.62 million, with shares are $6.42, and an 18.23 percent gain on the year.  The company’s dividend yield is 12.46 percent.

Dynex Capital Inc. (DX) – Dynex is an REIT that invests in mortgage loans and securities, with a market cap of $566.27 million, and shares at $10.44.  Up 13.60 percent this year, DX has an annual dividend yield of 11.11 percent.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer

Companies

Symbol Name Price Change % Volume
MITT AG Mortgage Investment Trust Inc. 17.28 0.00 0.00 484,685 Trade
AMTG Apollo Residential Mortgage Inc. n/a n/a n/a 0 Trade
DX Dynex Capital Inc. 6.07 -0.01 -0.16 646,391 Trade
VPG Vishay Precision Group Inc. 33.72 0.40 1.20 41,069 Trade
NYMT New York Mortgage Trust Inc. 6.31 0.01 0.16 886,434 Trade

Comments


Watchlist

Symbol Last Price Change % Change
AAPL

     
AMZN

     
HD

     
JPM

     
IBM

     
BA

     
WMT

     
DIS

     
XOM

     

Can the Media Solve the Partisan Conflict?

Andrew McCarthy, Contributing Editor, The National Review; Michael Zeldin, CNN Legal Analyst; Celeste Katz, Senior Political Reporter, Glamour; Silvia Davi, SVP, Contributing Editor, Equities.com; and Doug Simon, CEO, D S Simon Media discuss how the media’s role has shaped the landscape for communicators and what the media is trying to do to reduce discord in society.

Emerging Growth

IMV Inc.

Immunovaccine Inc is clinical stage biopharmaceutical company. The Company develops products based on its proprietary vaccine enhancement platform in T cell activating therapies for cancer.